Logistics of IND Submission: Best Practices for timely good quality IND application
The Content and Format of an IND
Lecture 6: Presenting Pre-clinical and Clinical Information in the IND
CMC Section of an IND
Best Practices for Maintaining an IND with the FDA
FDA Meetings and Other Regulatory Interactions
Who should Attend
Orphan drug developers
Sponsors of INDs
Project management personnel
Supervisors, and lead workers in Regulatory Affairs
Manufacturing managers, supervisors & personnel
Senior management executives (CEO, COO, CFO, etc)
People investing in FDA-regulated product development projects
Clinical and preclinical laboratory managers
Past Events
2-day In-person Seminar: Preparing IND Submissions for Conventional and Orphan Products 2012 - 11-12 Oct 2012, Hampton Inn Philadelphia City Center, Pennsylvania, United States (31622)
2-day In-person Seminar: Preparing IND Submissions for Conventional and Orphan Products 2026
Important
Please, check "2-day In-person Seminar: Preparing IND Submissions for Conventional and Orphan Products" official website for possible changes, before making any traveling arrangements
